Journal article icon

Journal article

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK

Abstract:

For patients with chronic myeloid leukaemia (CML), treatment guidelines recommend monitoring response to treatment with tyrosine kinase inhibitors (TKIs) by testing the BCR-ABL1 fusion gene transcript level using reverse transcriptase quantitative polymerase chain reaction. Despite recent efforts to standardise protocols for BCR-ABL1 testing, some variability remains among laboratories in the UK regarding the techniques used and the approach to reporting results. This increases the risk of mi...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's Version

Actions


Access Document


Files:
Publisher copy:
10.1111/bjh.15542

Authors


More by this author
Role:
Author
ORCID:
0000-0001-5481-2555
Expand authors...
Publisher:
John Wiley & Sons, Inc. Publisher's website
Journal:
British Journal of Haematology Journal website
Volume:
182
Issue:
6
Pages:
777-788
Publication date:
2018-08-20
Acceptance date:
2018-07-05
DOI:
EISSN:
1365-2141
ISSN:
0007-1048
Pubs id:
pubs:909834
URN:
uri:46335dc5-fe17-42bd-9244-786729795011
UUID:
uuid:46335dc5-fe17-42bd-9244-786729795011
Local pid:
pubs:909834

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP